WNT2 and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC), Wnt ligands (Wnt1, Wnt2, Wnt3, and Wnt5a) and other signaling modules (FZD8, PORCN, and TCF-4) are overexpressed [49].